Michele Esposito, MD, an interventional-heart failure cardiologist and assistant professor of medicine at the Charleston-based Medical University of South Carolina, received a Mentored ...

Research for other indications is ongoing. In the first trial of microRNA inhibition to treat heart failure, a novel agent did not reduce left ventricular end-systolic volume index at 6 months ...

In adults with congenitally corrected transposition of the great arteries (cc-TGA) and systemic right ventricular (RV) dysfunction, a greater use of guideline-directed medical therapy (GDMT) was ...

Heart failure sounds alarming—and rightfully so. Yet approximately 6.5 million Americans currently live with this condition, many with the specific variant called systolic heart failure, and a ...

USA: Researchers have discovered in a new study that an AI-based electrocardiogram (AI-ECG) algorithm demonstrated strong ...

Heart failure sounds scary – because it is. But here’s the thing: millions of Americans are walking around right now with a specific type called systolic heart failure, and many don’t even know it.

Findings from the TAVR UNLOAD study found limited benefits of transcatheter aortic valve replacement (TAVR) in the treatment of heart failure (HF) with reduced ejection fraction (HFrEF) and moderate ...

LBBB is linked to electrical abnormalities, causing inefficient heart pumping, dilation, and systolic dysfunction. The study found LBBB associated with increased heart failure risk, surpassing other ...

BACKGROUND: Heart failure with reduced ejection fraction (HFrEF) is characterized by impaired contractility and high ...